---
figid: PMC11884773__1414-431X-bjmbr-58-e14349-gf001
figtitle: Coptisine ameliorates colitis in mice by modulating cPLA2/TRPM8/CGRP-1 signaling
  pathways and strengthening intestinal barrier function
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11884773
filename: 1414-431X-bjmbr-58-e14349-gf001.jpg
figlink: /pmc/articles/PMC11884773/figure/F1/
number: F1
caption: 'Coptisine has been found to protect against colitis symptoms, improve intestinal
  barrier function in mice, upregulate TRP family proteins to modulate colon inflammation,
  reduce intestinal inflammation, and enhance mucosal barrier integrity. Its anti-inflammatory
  mechanism involves the cPLA2/TRPM8/CGRP-1 signaling pathway, offering a potential
  therapeutic strategy for treating ulcerative colitis. TNF-α: tumor necrosis factor-alpha;
  IFN-γ: interferon gamma; IL-6: interleukin 6; TRPM8: transient receptor potential
  cation subfamily M member 8; TRPV1: transient receptor potential vanilloid 1; TRPA1:
  transient receptor potential ankyrin 1; cPLA2 cytosolic phospholipase A2; CGRP-1:
  calcitonin gene-related peptide-1'
papertitle: Coptisine ameliorates colitis in mice by modulating cPLA2/TRPM8/CGRP-1
  signaling pathways and strengthening intestinal barrier function
reftext: Wenbin Wu, et al. Braz J Med Biol Res. 2025 Mar 03;58(NA).
year: '2025'
doi: 10.1590/1414-431X2025e14349
journal_title: Brazilian Journal of Medical and Biological Research
journal_nlm_ta: Braz J Med Biol Res
publisher_name: Associação Brasileira de Divulgação Científica
keywords: Coptisine | Ulcerative colitis | TRPM8 | Network pharmacology
automl_pathway: 0.9563098
figid_alias: PMC11884773__F1
figtype: Figure
redirect_from: /figures/PMC11884773__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11884773__1414-431X-bjmbr-58-e14349-gf001.html
  '@type': Dataset
  description: 'Coptisine has been found to protect against colitis symptoms, improve
    intestinal barrier function in mice, upregulate TRP family proteins to modulate
    colon inflammation, reduce intestinal inflammation, and enhance mucosal barrier
    integrity. Its anti-inflammatory mechanism involves the cPLA2/TRPM8/CGRP-1 signaling
    pathway, offering a potential therapeutic strategy for treating ulcerative colitis.
    TNF-α: tumor necrosis factor-alpha; IFN-γ: interferon gamma; IL-6: interleukin
    6; TRPM8: transient receptor potential cation subfamily M member 8; TRPV1: transient
    receptor potential vanilloid 1; TRPA1: transient receptor potential ankyrin 1;
    cPLA2 cytosolic phospholipase A2; CGRP-1: calcitonin gene-related peptide-1'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PLA2G4A
  - KAT5
  - TRPA1
  - TRPM8
  - TRPV1
  - TNF
  - CDH1
  - FZR1
  - IL6
  - CALCA
  - TNF-a
  - Colitis
  - Ulcerative Colitis
---
